Dapper Hendrik, Oertelt-Prigione Sabine, Stadler Gertraud, Weishaupt Nina, Quaas Alexander, Romotzky Vanessa, Haarmann Lena, Fokas Emmanouil, Fan Jiaqi, Linde Philipp, Zander Thomas, Görner Martin, Wortmann Laura
Department of Radiation Oncology, Cyberknife and Radiotherapy, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine Cologne, University Hospital Cologne, Cologne, Germany.
WG Sex- and Gender-Sensitive Medicine, Medical Faculty OWL, University of Bielefeld, Germany; Gender Unit, Department of Primary and Community Care, Radboudumc, Nijmegen, NL, the Netherlands.
Transl Oncol. 2025 Oct;60:102493. doi: 10.1016/j.tranon.2025.102493. Epub 2025 Aug 8.
• Diversity remains underrepresented in oncology care and research in Germany. • Several domains such as biological sex and age affect cancer therapy efficacy and toxicity. • Socioeconomic disadvantage reduces access to screening and trial participation. • Inclusive strategies are needed in clinical care, trials, and institutional structures. • Practical, scalable recommendations are proposed for German oncology departments.
• 在德国，肿瘤护理和研究中多样性的体现仍然不足。
• 生物性别和年龄等多个领域会影响癌症治疗的疗效和毒性。
• 社会经济劣势会减少筛查和参与试验的机会。
• 临床护理、试验和机构结构中需要采用包容性策略。
• 为德国肿瘤科室提出了切实可行、可扩展的建议。
